Kuan Jew Win

Dr Kuan is currently a Professor and Consultant Haematologist at the Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak .

Working in Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak as Professor and Consultant Haematologist

Selected publications

1. Kuan JW, Pathmanathan R, Chang KM, Tan SM. Aleukemic bcr-abl positive granulocytic sarcoma. Leukemia research. 2009;33(11):1574-7. doi:10.1016/j.leukres.2009.01.016.

2. Kuan JW, Chang KM, Lau NS, Visalachy P, Tan SM, Ong TC et al. The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. 2011;27(3):136-45. doi:10.1007/s12288-011-0077-z.

3. Kuan J-W, Su Anselm T, Leong C-F. Pegylated granulocyte colony stimulating factor versus non-pegylated granulocyte colony stimulating factor for patients after hematopoietic stem cell transplantation. Cochrane Database of Systematic Reviews 2012 doi:10.1002/14651858.CD010104.

4. Kuan J-W, Su Anselm T, Leong C-F. Pegylated granulocyte colony stimulating factor versus non-pegylated granulocyte colony stimulating factor for peripheral stem cell mobilization. Cochrane Database of Systematic Reviews 2012 doi:10.1002/14651858.CD010103.

5. Kuan JW, Su AT, Wong SP, Sim XY, Toh SG, Ong TC et al. A randomized double blind control trial comparing filgrastim and pegfilgrastim in cyclophosphamide peripheral blood hematopoietic stem cell mobilization. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2015;53(2):196-204. doi:10.1016/j.transci.2015.03.017.

6. Kuan JW, Law CS, Wong XQ, Ko CT, Awang ZH, Chew LP et al. A pioneer experience in Malaysia on In-house Radio-labelling of (131)I-rituximab in the treatment of Non-Hodgkin's Lymphoma and a case report of high dose (131)I-rituximab-BEAM conditioning autologous transplant. Appl Radiat Isot. 2016;116:13-21. doi:10.1016/j.apradiso.2016.07.016.

7. Kuan JW, Su AT, Leong CF. Pegylated granulocyte-colony stimulating factor versus non-pegylated granulocyte-colony stimulating factor for peripheral blood stem cell mobilization: A systematic review and meta-analysis. J Clin Apher. 2017;32(6):517-42. doi:10.1002/jca.21550.

8. Kuan JW, Melaine Michael S. The epidemiology of chronic myeloid leukaemia in southern Sarawak, Borneo Island. Med J Malaysia. 2018;73(2):78-85.

9. Kuan JW, Su AT, Leong CF, Osato M, Sashida G. Systematic review of pre-clinical chronic myeloid leukaemia. Int J Hematol. 2018;108(5):465-84. doi:10.1007/s12185-018-2528-x.

10. Kuan JW, Su AT, Leong CF, Osato M, Sashida G. Correction to: Systematic review of pre-clinical chronic myeloid leukaemia. Int J Hematol. 2019;109(1):130. doi:10.1007/s12185-018-2556-6.

11. Kuan JW, Su AT, Leong CF, Osato M, Sashida G. Systematic Review of Normal Subjects Harbouring BCR-ABL1 Fusion Gene. Acta Haematol. 2019. doi:10.1159/000501146.

12. Ting CY, Chang KM, Kuan JW, Sathar J, Chew LP, Wong OJ et al. Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients. Int J Med Sci. 2019;16(4):556-66. doi:10.7150/ijms.27610.

13. Kuan JW, Su AT, Tay SP, Fong IL, Kubota S, Su'ut L et al. Low prevalence of the BCR-ABL1 fusion gene in a normal population in southern Sarawak. Int J Hematol. 2019. doi:10.1007/s12185-019-02768-x.